Neuroimaging: do we really need new contrast agents for MRI? (Q30605570)

25 June 2017

1 reference

title

Neuroimaging: do we really need new contrast agents for MRI? (English)

1 reference

25 June 2017

0 references

1 reference

Roberts TP

1

1 reference

25 June 2017

Chuang N

series ordinal

2

1 reference

25 June 2017

Roberts HC

series ordinal

3

1 reference

25 June 2017

publication date

1 June 2000

1 reference

European Journal of Radiology

25 June 2017

published in

1 reference

25 June 2017

volume

34

1 reference

25 June 2017

issue

3

1 reference

25 June 2017

page(s)

166-178

1 reference

Safety and efficacy of dotarem (Gd-DOTA) versus magnevist (Gd-DTPA) in magnetic resonance imaging of the central nervous system

25 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2800%2900197-2

7 January 2021

Synergistic Enhancement of MRI with Gd-DTPA and Magnetization Transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2800%2900197-2

7 January 2021

Effects of contrast dose, delayed imaging, and magnetization transfer saturation on gadolinium-enhanced MR imaging of brain lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2800%2900197-2

7 January 2021

Contrast-enhanced magnetic resonance angiography of cerebral arteries. A review

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2800%2900197-2

7 January 2021

Optimization of gadolinium-enhanced magnetic resonance angiography using an automated bolus-detection algorithm (MR SmartPrep). Original investigation.

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2800%2900197-2

7 January 2021

Time-resolved contrast-enhanced 3D MR angiography

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2800%2900197-2

7 January 2021

High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: Experimental comparison and preliminary results.

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2800%2900197-2

7 January 2021

Dynamic imaging with lanthanide chelates in normal brain: Contrast due to magnetic susceptibility effects

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2800%2900197-2

7 January 2021

Perfusion imaging with NMR contrast agents

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2800%2900197-2

7 January 2021

Functional cerebral imaging by susceptibility-contrast NMR.

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2800%2900197-2

7 January 2021

Echo-planar perfusion-sensitive MR imaging of acute cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2800%2900197-2

7 January 2021

High-speed MR imaging of ischemic brain injury following stenosis of the middle cerebral artery

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2800%2900197-2

7 January 2021

Sensitivity of high-speed "perfusion-sensitive" magnetic resonance imaging to mild cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2800%2900197-2

7 January 2021

Contrast agents in functional MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2800%2900197-2

7 January 2021

Dynamic contrast-enhanced T2*-weighted MRI in patients with cerebrovascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2800%2900197-2

7 January 2021

Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2800%2900197-2

7 January 2021

Utility of relative cerebral blood volume mapping derived from perfusion magnetic resonance imaging in the routine follow up of brain tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2800%2900197-2

7 January 2021

Effect of radiation on blood volume in low-grade astrocytomas and normal brain tissue: quantification with dynamic susceptibility contrast MR imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2800%2900197-2

7 January 2021

Dynamic susceptibility contrast magnetic resonance imaging in neuropsychiatry: present utility and future promise

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2800%2900197-2

7 January 2021

Applications of dynamic susceptibility contrast magnetic resonance imaging in Neuropsychiatry

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2800%2900197-2

7 January 2021

Regional cerebral blood volume measured by dynamic susceptibility contrast MR imaging in Alzheimer's disease: a principal components analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2800%2900197-2

7 January 2021

Increased cerebral blood volume in HIV-positive patients detected by functional MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2800%2900197-2

7 January 2021

Cerebral toxoplasmosis and lymphoma in AIDS: perfusion MR imaging experience in 13 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2800%2900197-2

7 January 2021

Abnormalities of regional distribution of cerebral vasculature in schizophrenia detected by dynamic susceptibility contrast MRI

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2800%2900197-2

7 January 2021

Cocaine-induced changes in time course of regional cerebral blood volume and transit time as determined by dynamic MR imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2800%2900197-2

7 January 2021

Cocaine decreases relative cerebral blood volume in humans: a dynamic susceptibility contrast magnetic resonance imaging study.

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2800%2900197-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0720-048X%2800%2900197-2

1 reference

7 January 2021

Echo-planar MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2800%2900197-2

7 January 2021

Nonionic iodinated contrast media: potential renal damage assessed with enzymuria

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2800%2900197-2

7 January 2021

Perfusion CT of the brain: diagnostic approach for early detection of ischemic stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2800%2900197-2

7 January 2021

Simultaneous assessment of cerebral hemodynamics and contrast agent uptake in lesions with disrupted blood-brain-barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2800%2900197-2

7 January 2021

Comparison of cerebral blood volume measurements using the T1 and T2* methods in normal human brains and brain tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2800%2900197-2

7 January 2021

Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2800%2900197-2

7 January 2021

Magnetic resonance imaging detects suppression of tumor vascular permeability after administration of antibody to vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2800%2900197-2

7 January 2021

Pharmacokinetic MRI for assessment of malignant glioma response to stereotactic radiotherapy: initial results.

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2800%2900197-2

7 January 2021

MS-325: albumin-targeted contrast agent for MR angiography

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2800%2900197-2

7 January 2021

Angiographic properties of Gd-DTPA-24-cascade-polymer — a new macromolecular MR contrast agent

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2800%2900197-2

7 January 2021

Steady-state and dynamic MR angiography with MS-325: initial experience in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2800%2900197-2

7 January 2021

Improved delineation of human brain tumors on MR images using a long-circulating, superparamagnetic iron oxide agent

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2800%2900197-2

7 January 2021

Application of a superparamagnetic iron oxide (Resovist) for MR imaging of human cerebral blood volume

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2800%2900197-2

7 January 2021

Functional mapping of the human visual cortex by magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2800%2900197-2

7 January 2021

High-resolution functional magnetic resonance imaging of the rat brain: mapping changes in cerebral blood volume using iron oxide contrast media.

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2800%2900197-2

7 January 2021

Manganese ion enhances T1-weighted MRI during brain activation: an approach to direct imaging of brain function

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2800%2900197-2

7 January 2021

In vivo macrophage activity imaging in the central nervous system detected by magnetic resonance

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2800%2900197-2

7 January 2021

Biological magnetic resonance imaging using laser-polarized 129Xe.

1 reference

https://api.crossref.org/works/10.1016%2FS0720-048X%2800%2900197-2

7 January 2021

10.1016/S0720-048X(00)00197-2

Identifiers

DOI

1 reference

25 June 2017

1 reference